How many institutions held BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 in Q1 2020?

68 institutional investors reported BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 for Q1 2020. Use the holders table for investor-level position and value details.

BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI)

Q: What does CUSIP 09075P105 represent in this 13F holders report?

CUSIP 09075P105 is the security identifier for BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 used to aggregate holder disclosures.

CUSIP: 09075P105

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock, par value $0.001
Shares outstanding: 26,011,000
Total 13F shares: 5,997,060
Share change: +1,647,462
Total reported value: $133,825,071
Put/Call ratio: 49%
Price per share: $22.35
Number of holders: 68
Value change: +$39,824,964
Number of buys: 46
Number of sells: 25

Quarterly Holders Quick Answers

What is CUSIP 09075P105?
CUSIP 09075P105 identifies BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 09075P105:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Artemis Investment Management LLP	13F	Company	4.1%	1,073,591	$15,508,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	3.5%	910,589	$13,304,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	1.5%	400,565	$5,852,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	1.5%	387,624	$5,663,000	—	31 Dec 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	1.2%	315,700	$4,612,000	—	31 Dec 2019	13F
Point72 Asset Management, L.P.	13F	Company	0.98%	255,000	$3,726,000	—	31 Dec 2019	13F
Ikarian Capital, LLC	13F	Company	0.61%	158,373	$2,314,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.45%	118,302	$1,729,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	0.38%	99,950	$1,460,000	—	31 Dec 2019	13F
UBS Group AG	13F	Company	0.36%	93,084	$1,360,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.3%	79,204	$1,157,000	—	31 Dec 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.29%	74,900	$1,094,000	—	31 Dec 2019	13F
DLD Asset Management, LP	13F	Company	0.25%	65,408	$956,000	—	31 Dec 2019	13F
BANCO BILBAO VIZCAYA ARGENTARIA, S.A.	13F	Company	0.19%	50,000	$730,000	—	31 Dec 2019	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.1%	26,255	$384,000	—	31 Dec 2019	13F
Squarepoint Ops LLC	13F	Company	0.09%	23,118	$338,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.07%	19,423	$284,000	—	31 Dec 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.07%	19,219	$281,000	—	31 Dec 2019	13F
Verition Fund Management LLC	13F	Company	0.07%	16,996	$248,000	—	31 Dec 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.06%	16,720	$244,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.06%	15,642	$227,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.06%	15,092	$221,000	—	31 Dec 2019	13F
Creative Planning	13F	Company	0.06%	14,850	$217,000	—	31 Dec 2019	13F
Game Plan Financial Advisors, LLC	13F	Company	0.05%	12,500	$183,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.04%	10,694	$156,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.04%	10,201	$149,000	—	31 Dec 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.04%	9,282	$136,000	—	31 Dec 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.04%	9,200	$134,000	—	31 Dec 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.04%	9,144	$134,000	—	31 Dec 2019	13F
STRS OHIO	13F	Company	0.03%	8,500	$124,000	—	31 Dec 2019	13F
BARCLAYS PLC	13F	Company	0.03%	6,939	$101,000	—	31 Dec 2019	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.02%	4,346	$63,000	—	31 Dec 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	2,593	$38,000	—	31 Dec 2019	13F
AllSquare Wealth Management LLC	13F	Company	0.01%	1,810	$26,000	—	31 Dec 2019	13F
Point72 Hong Kong Ltd	13F	Company	0.01%	1,528	$22,000	—	31 Dec 2019	13F
CITIGROUP INC	13F	Company	0.01%	1,391	$20,000	—	31 Dec 2019	13F
Legal & General Group Plc	13F	Company	0%	1,230	$18,000	—	31 Dec 2019	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0%	1,000	$15,000	—	31 Dec 2019	13F
BANK OF MONTREAL /CAN/	13F	Company	0%	940	$14,000	—	31 Dec 2019	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	891	$13,018	—	31 Dec 2019	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	531	$8,000	—	31 Dec 2019	13F
ROYAL BANK OF CANADA	13F	Company	0%	412	$6,000	—	31 Dec 2019	13F
MEEDER ASSET MANAGEMENT INC	13F	Company	0%	55	$1,000	—	31 Dec 2019	13F

Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) as of Q1 2020

As of 31 Mar 2020, BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) was held by 68 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,997,060 shares. The largest 10 holders included Artemis Investment Management LLP, Ikarian Capital, LLC, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, ACUTA CAPITAL PARTNERS, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Avidity Partners Management LP, and Nuveen Asset Management, LLC. This page lists 68 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

Q1 2020 holders

Holder diff

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.